David S. Slack
David Slack is the President and Chief Business Officer of Lisata Therapeutics, Inc. He is a seasoned industry executive with over 25 years of experience in public and private life science companies. He has been responsible for numerous company financings, mergers and acquisitions, strategic alliances, and other partnerships. Prior to the merger closing, forming Lisata, David served as President, Chief Executive Officer, and Director of Cend Therapeutics. Prior to his role at Cend, he served as co-founding Chief Business Officer at Viracta Therapeutics. David also served as Vice President for Business Development at Ionis Pharmaceuticals and served in senior management positions at Rhône-Poulenc Rorer, RPR Gencell and Aventis Pharmaceuticals.